|
Volumn 2, Issue 1, 2001, Pages 1-5
|
Nelfinavir plus nevirapine plus two NRTIs as salvage therapy for HIV-infected patients receiving long-term antiretroviral treatment
a a a a a a a a |
Author keywords
Nelfinavir; Nevirapine; Rescue therapy
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ANTIRETROVIRUS AGENT;
ASPARTATE AMINOTRANSFERASE;
BILIRUBIN;
CD4 ANTIGEN;
COMPLEMENTARY DNA;
CYTOCHROME P450;
DIDANOSINE;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
NEW DRUG;
NUCLEOSIDE DERIVATIVE;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS DNA;
VIRUS ENZYME;
VIRUS RNA;
ZIDOVUDINE;
ADULT;
ANTIVIRAL ACTIVITY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG RESPONSE;
FEMALE;
GENOTYPE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LONG TERM CARE;
LYMPHOCYTE COUNT;
MALE;
NONHUMAN;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RASH;
SALVAGE THERAPY;
STRAIN DIFFERENCE;
T LYMPHOCYTE;
VIRUS LOAD;
VIRUS STRAIN;
|
EID: 0035116828
PISSN: 15284336
EISSN: None
Source Type: Journal
DOI: 10.1310/0LNV-BX4E-EUF4-F18T Document Type: Article |
Times cited : (4)
|
References (16)
|